Clinical and laboratory findings of the first imported case of middle east respiratory syndrome coronavirus to the United States

Clinical Infectious Diseases

Volumn 59, Issue 11, 2014, Pages 1511-1518

  Kapoor, Minal ^a   Pringle, Kimberly ^c   Kumar, Alan ^a   Dearth, Stephanie ^b   Liu, Lixia ^b   Lovchik, Judith ^b   Perez, Omar ^b   Pontones, Pam ^b   Richards, Shawn ^b   Yeadon Fagbohun, Jaime ^b   Breakwell, Lucy ^c   Chea, Nora ^c   Cohen, Nicole J ^d   Schneider, Eileen ^c   Erdman, Dean ^c   Haynes, Lia ^c   Pallansch, Mark ^c   Tao, Ying ^c   Tong, Suxiang ^c   Gerber, Susan ^c   Swerdlow, David ^e   Feikin, Daniel R ^c   more..

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INDIANA STATE DEPARTMENT OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Middle east respiratory syndrome coronavirus; Viral pneumonia

Indexed keywords

ATENOLOL; ATORVASTATIN; CEFTRIAXONE; CIPROFLOXACIN; CLOPIDOGREL; FUROSEMIDE; IMMUNOGLOBULIN; LEVOFLOXACIN; LINEZOLID; NAPROXEN; OSELTAMIVIR; PARACETAMOL; PIPERACILLIN; SALBUTAMOL; TAZOBACTAM; VALSARTAN; VANCOMYCIN;

ABNORMAL RESPIRATORY SOUND; ADD ON THERAPY; AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONAVIRUS INFECTION; COUGHING; DISEASE COURSE; DIURESIS; DYSPNEA; EMERGENCY WARD; FATIGUE; FEVER; FOLEY BALLOON CATHETER; HOSPITAL; HOSPITAL ACQUIRED PNEUMONIA; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPONATREMIA; HYPOXIA; INFECTION CONTROL; LIVER FUNCTION TEST; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALAISE; MALE; MEDICAL HISTORY; MEDICAL NEBULIZER; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MYALGIA; NASAL CANNULA; NUCLEOTIDE SEQUENCE; OXYGEN THERAPY; PHYSICIAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATITIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAUDI ARABIA; SURGICAL MASK; TACHYPNEA; THORAX RADIOGRAPHY; UNITED STATES; VIRUS LOAD; VIRUS PNEUMONIA; CORONAVIRUS INFECTIONS; ISOLATION AND PURIFICATION; PATHOLOGY; TRAVEL; VIROLOGY;

AGED; CORONAVIRUS INFECTIONS; HUMANS; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SAUDI ARABIA; TRAVEL; UNITED STATES;

EID: 84922905284     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu635     Document Type: Article

References (26)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-20.
2. World Health Organization. Coronavirus infections. Available at: http://www.who.int/csr/disease/coronavirus-infections/en/. Accessed 12 May 2014.
3. Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160: 389-97.
4. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13: 752-61.
5. Centers for Disease Control and Prevention. Updated information on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection and guidance for the public, clinicians, and public health authorities, 2012-2013. MMWR Morb Mortal Wkly Rep 2013; 62: 793-6.
6. World Health Organization. Global alert and response. Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update - as of 9 May 2014. Available at: http://www.who.int/csr/disease/coronavirus-infections/MERS-CoV-Update-09-May-2014.pdf?ua=1. Accessed 15 July 2014.
7. Centers for Disease Control and Prevention. First confirmed Middle East respiratory syndrome coronavirus (MERS-CoV) cases in the United States and updated information on the epidemiology of MERS-CoV infection and guidance for the public, clinicians, and public health authorities, May 2014. MMWR Morb Mortal Wkly Rep 2014; 19: 431-6.
8. Lu X, Whitaker B, Sakthivel SK, et al. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol 2014; 52: 67-75.
9. Al-Abdallat MM, Payne D, Alqasrawi S, et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 2014; 59: 1225-33.
10. Sui J, Li W, Murakami A, et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 2004; 101: 2536-41.
11. Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369: 407-16.
12. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013; 368: 2487-94.
13. Centers for Disease Control and Prevention. Interim guidance for health professionals. Available at: http://www.cdc.gov/coronavirus/mers/interim-guidance.html. Accessed 12 May 2014.
14. World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus. Interim recommendations - September 2013. Available at: http://www.who.int/csr/disease/coronavirus-infections/MERS-Lab-recos-16-Sept-2013.pdf. Accessed 12 May 2014.
15. Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 2013; 381: 2265-72.
16. Drosten C, Seilmaier M, Corman VM, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013; 13: 745-51.
17. He Z, Zhuang H, Zhao C, Dong Q, Peng G, Dwyer DE. Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV). Virol J 2007; 4: 32.
18. Tang P, Louie M, Richardson SE, et al. Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ 2004; 170: 47-54.
19. Cheng PK, Wong DA, Tong LK, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 2004; 363: 1699-700.
20. Centers for Disease Control and Prevention. MERS-CoV case definitions. Available at: http://www.cdc.gov/coronavirus/mers/case-def.html. Accessed 13 June 2014.
21. World Health Organization. Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do. Available at: http://www.who.int/csr/disease/coronavirus-infections/InterimGuidance-ClinicalManagement-NovelCoronavirus-11Feb13.pdf. Accessed 12 May 2014.
22. McCullers JA Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19: 571-82.
23. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006; 3: e343.
24. Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H. Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin. Sci Rep 2013; 3: 1686.
25. Falzarano D, de Wit E, Rasmussen AL, et al. Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 2013; 19: 1313-7.
26. Memish ZA, Cotten M, Watson SJ, et al. Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. Int J Infect Dis 2014; 23: 63-8.